#Ophthalmology #Ophthotwitter #Scicomm GLP-1 RAs and eye problems: A global study Ophthopedia Update:Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective treatments for type 2 diabetes (T2DM), obesity, and cardiovascular disease.13 Beyond these indications, they have shown promising clinical efficacy in conditions such as chronic kidney disease, metabolic dysfunctionassociated steatohepatitis, obstructive sleep apnea, and Parkinsons disease.46 With proven efficacy and increasing global use, there is a growing need to better understand the potential complications of GLP-1 RA therapy
A potential loss of strength when taking Ozempic may be of particular concern for adults over the age of 60, who are at higher baseline risk for muscle loss and reduced mobility
It is usually prescribed when other medications, like metformin, are not enough to control blood sugar levels
She says it can serve as a light meal replacement in a pinch because it is high in protein and nutrient dense while remaining low in calories
A trial period of 2-3 months is reasonable to assess response
You can also view your treatment schedule as well as set up reminders to help stay on track